The FAP Gene Support Group

(Familial Adenomatous Polyposis)

Homepage About us Trials Menu Worldwide Trial Desmoid Trial Curcumin
Comparison of Trials Curcumin Personal Trial Curcumin Research Curcumin Suppliers More studies on Curcumin Disclaimer

Curcumin - University of Leicester Research

An extract from Curry Spice Turmeric 'could help cure cancer'

Two Articles - Press Releases below

May 2012 University of Leicester Website Link

September 2010 University of Leicester Website Link

Trial launched into curry chemical's cancer-fighting properties
May 07, 2012 12:05 AM

Effects of curcumin in chemotherapy investigated by University of Leicester

Issued by Cancer Research UK and University of Leicester on 7 May 2012

COMPOUNDS found in curry are being investigated as a way of improving drug response in patients with advanced bowel cancer in a new study launched today (Monday).

Scientists at the Cancer Research UK and National Institute for Health Research Experimental Cancer Medicine Centre (ECMC) in Leicester will investigate whether tablets containing curcumin – found in the spice turmeric – can be safely added to the standard treatment for bowel cancer that has spread.

Earlier studies have shown that curcumin can enhance the ability of chemotherapy to kill bowel cancer cells in the lab.

The trial is being funded by Hope Against Cancer, The Royal College of Surgeons and the Bowel Disease Research Foundation.

Patients with advanced bowel cancer are usually given a treatment called FOLFOX, which combines three chemotherapy drugs. But around 40-60 per cent of patients don’t respond and, of those who do, side effects such as severe tingling or nerve pain can limit the number of cycles patients can have.

Chief investigator Professor William Steward, ECMC director at the University of Leicester, said: “Once bowel cancer has spread it is very difficult to treat, partly because the side effects of chemotherapy can limit how long patients can have treatment. The prospect that curcumin might increase the sensitivity of cancer cells to chemotherapy is exciting because it could mean giving lower doses, so patients have fewer side effects and can keep having treatment for longer.

“This research is at a very early stage, but investigating the potential of plant chemicals to treat cancer is an intriguing area that we hope could provide clues to developing new drugs in the future.”

Around 40 patients with bowel cancer that has spread to the liver will be recruited to take part in the study at Leicester Royal Infirmary and Leicester General Hospital. Three quarters of these will be given curcumin tablets for seven days, before being treated with FOLFOX. The remainder will receive FOLFOX only.

Colin Carroll, a 62-year-old compliance consultant from near Loughborough, agreed to take part in the trial after being diagnosed with advanced bowel cancer in January.

“The diagnosis came as a big shock because I’d had no symptoms apart from some occasional cramps,” said Colin.

“I’d had a few tests which had come back clear and I’d just been booked for a CT scan when I was rushed to hospital with a suspected intestinal blockage.”

Scans showed Colin had bowel cancer which had spread to his liver and, three days after being admitted to Leicester Royal Infirmary, he underwent an emergency ileostomy to bypass the blockage.

“It’s been like a whirlwind,” said Colin who will need to undergo chemotherapy until mid-August. “To have something creep up on you like that when you have absolutely no control over it really makes you want to fight back. That’s why I had no difficulty in agreeing to take part in the trial.

“I’ve met some amazing people since January and my treatment on the NHS has been fantastic. The way I see it is that I’m being given the best possible chance so in that sense I feel very fortunate.”

Dr Joanna Reynolds, Cancer Research UK’s director of centres, said: “The Experimental Cancer Medicine Centres Network supports research into some of the most novel and exciting new anti-cancer therapies, often providing the first insights into their effect on cancer patients. By doing a clinical trial like this we will find out more about the potential benefits of taking large amounts of curcumin, as well as any possible side effects this could have for cancer patients.”

ENDS

For media enquiries, please contact Ailsa Stevens in the Cancer Research UK press office on 020 3469 8300 or, out of hours, 07050 264 059.

Press Release September 2010

An extract from the common curry spice turmeric could help cure cancer, researchers believe.

Curcumin, an extract of the root turmeric, has the ability to kill off cancer cells which are resistant to chemotherapy, scientists at the University of Leicester think.

They have been using tissue from tumours of bowel cancer patients to test their theory.

Dr Karen Brown, of the Department of Cancer Studies and Molecular Medicine, said: "Tumours are made up of different types of cells and some are resistant to chemotherapy treatment which, in some cases, causes the tumours to grow back.

"We aren't yet treating patients but looking at cells to see how effective curcumin is in killing off the resistant stem cells."

Laboratory research shows that curcumin, when combined with other chemotherapy drugs, has the ability to destroy the resistant cells. Clinical trials have yet to be carried out.

Dr Brown said: "It is a big step but it is still likely to take at least five to 10 years before it becomes part of treatment."

Dr Lynne Howells, a senior research fellow at the university who is leading the study, said: "We are primarily looking at treatment for bowel cancer where the cancer has spread to the liver.

"However, the work could have much wider implications in the treatment of other cancers."

Researchers now hope to carry out a study with patients suffering from bowel cancer to test the safety and quantities of curcumin which should be given.

Dr Howells said: "We will start with a small dose – the equivalent contained, for example, in a normal curry. We are now hoping to give increasing amounts to patients receiving chemotherapy."

But she warned patients should not rush out and have a curry thinking it will do the trick.

"We don't yet know all the effects of circumin and the amounts that should be given, she said.

"All this does need to be done in a controlled environment."

The work has won £75,000 worth of funding over the next three years from Leicestershire charity, Hope Against Cancer Website Link ,which Dr Howells said "allows us to expand our promising research".

The charity was founded in 2002 by the late Allison Wilson, a former High Sheriff of Leicestershire, after she was diagnosed with cancer and realised funding was needed to develop care in Leicestershire and Rutland. Wendi Stevens, from the charity, said: "It is thanks to a team of dedicated volunteers and fund-raisers that we are able to fund exciting research such as this in Leicester."

Go to Top of Page